27 July 2017

A follow-up study evaluated the safety and efficacy to the dapivirine vaginal ring as a means of HIV prevention among adolescent girls. It found that using the ring reduced young women's risk of HIV by a promising 56%. The sample of this study consisted of 96 sexually-active girls, between ages 15-17, in the United States. The ring was deemed safe and acceptable in adolescent girls in the United States and the research will now extend further to African adolescent girls ages 16-21.

Read the full article online here.